Showing 1 - 8 results of 8 for search 'Sara Anjomani-Virmouni', query time: 0.04s Refine Results
  1. 1
    PARK2 loss promotes cancer progression via redox-mediated inactivation of PTEN

    PARK2 loss promotes cancer progression via redox-mediated inactivation of PTEN by Amit Gupta, Sara Anjomani-Virmouni, Nikos Koundouros, George Poulogiannis

    Published 2017-11-01
    Get full text
    Article
  2. 2
    Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich ataxia.

    Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich ataxia. by Sara Anjomani Virmouni, Chiranjeevi Sandi, Sahar Al-Mahdawi, Mark A Pook

    Published 2014-01-01
    Get full text
    Article
  3. 3
    Emerging antioxidant therapies in Friedreich’s ataxia

    Emerging antioxidant therapies in Friedreich’s ataxia by Fred Jonathan Edzeamey, Zenouska Ramchunder, Charareh Pourzand, Charareh Pourzand, Sara Anjomani Virmouni

    Published 2024-02-01
    Get full text
    Article
  4. 4
    MutLα heterodimers modify the molecular phenotype of Friedreich ataxia.

    MutLα heterodimers modify the molecular phenotype of Friedreich ataxia. by Vahid Ezzatizadeh, Chiranjeevi Sandi, Madhavi Sandi, Sara Anjomani-Virmouni, Sahar Al-Mahdawi, Mark A Pook

    Published 2014-01-01
    Get full text
    Article
  5. 5
    Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models.

    Generation and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell models. by Chiranjeevi Sandi, Madhavi Sandi, Harvinder Jassal, Vahid Ezzatizadeh, Sara Anjomani-Virmouni, Sahar Al-Mahdawi, Mark A Pook

    Published 2014-01-01
    Get full text
    Article
  6. 6
    A novel GAA-repeat-expansion-based mouse model of Friedreich’s ataxia

    A novel GAA-repeat-expansion-based mouse model of Friedreich’s ataxia by Sara Anjomani Virmouni, Vahid Ezzatizadeh, Chiranjeevi Sandi, Madhavi Sandi, Sahar Al-Mahdawi, Yogesh Chutake, Mark A. Pook

    Published 2015-03-01
    Get full text
    Article
  7. 7
    HMTase Inhibitors as a Potential Epigenetic-Based Therapeutic Approach for Friedreich’s Ataxia

    HMTase Inhibitors as a Potential Epigenetic-Based Therapeutic Approach for Friedreich’s Ataxia by Mursal Sherzai, Adamo Valle, Adamo Valle, Nicholas Perry, Ester Kalef-Ezra, Sahar Al-Mahdawi, Mark Pook, Sara Anjomani Virmouni

    Published 2020-06-01
    Get full text
    Article
  8. 8
    A new FRDA mouse model [Fxnnull:YG8s(GAA) > 800] with more than 800 GAA repeats

    A new FRDA mouse model [Fxnnull:YG8s(GAA) > 800] with more than 800 GAA repeats by Ester Kalef-Ezra, Fred Jonathan Edzeamey, Adamo Valle, Adamo Valle, Adamo Valle, Hassan Khonsari, Paula Kleine, Carlo Oggianu, Sahar Al-Mahdawi, Mark A. Pook, Sara Anjomani Virmouni

    Published 2023-01-01
    Get full text
    Article

Search Tools: